CVE:PBS - Pacgen Life Science Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$0.03 0.00 (0.00 %)
(As of 02/22/2019 04:00 PM ET)
Previous CloseC$0.03
Today's RangeC$0.03 - C$0.03
52-Week RangeC$0.02 - C$0.08
Average Volume22,740 shs
Market CapitalizationC$1.94 million
P/E Ratio-6.00
Dividend YieldN/A
Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.

Receive PBS News and Ratings via Email

Sign-up to receive the latest news and ratings for PBS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$607,071.00
Cash FlowC$0.01 per share
Book ValueC$0.01 per share



Market CapC$1.94 million
Next Earnings Date3/7/2019 (Estimated)
OptionableNot Optionable

Pacgen Life Science (CVE:PBS) Frequently Asked Questions

What is Pacgen Life Science's stock symbol?

Pacgen Life Science trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PBS."

When is Pacgen Life Science's next earnings date?

Pacgen Life Science is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Pacgen Life Science.

Has Pacgen Life Science been receiving favorable news coverage?

Media headlines about PBS stock have been trending somewhat positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pacgen Life Science earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term.

Who are some of Pacgen Life Science's key competitors?

What other stocks do shareholders of Pacgen Life Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pacgen Life Science investors own include

Who are Pacgen Life Science's key executives?

Pacgen Life Science's management team includes the folowing people:
  • Mr. Chung-Yu Wang B.Sc., Ph.D., EMBA, Co-Founder & Chairman (Age 74)
  • Ms. Christina Yip, CEO & Pres (Age 55)
  • Ms. Andrea Chan, Interim Chief Financial Officer
  • Mr. Ivan Wong, Exec. VP of Operations
  • Ms. Julie P. Rezler, VP of Corp. Devel.

How do I buy shares of Pacgen Life Science?

Shares of PBS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Pacgen Life Science's stock price today?

One share of PBS stock can currently be purchased for approximately C$0.03.

How big of a company is Pacgen Life Science?

Pacgen Life Science has a market capitalization of C$1.94 million and generates C$607,071.00 in revenue each year.

What is Pacgen Life Science's official website?

The official website for Pacgen Life Science is

How can I contact Pacgen Life Science?

Pacgen Life Science's mailing address is 666 Burrard St Suite 500, VANCOUVER, BC V6C 3P6, Canada. The company can be reached via phone at +1-604-4364388.

MarketBeat Community Rating for Pacgen Life Science (CVE PBS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  68
MarketBeat's community ratings are surveys of what our community members think about Pacgen Life Science and other stocks. Vote "Outperform" if you believe PBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel